Speciality Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Education Dialogues
    • Business Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Speciality Medical Dialogues
    • Editorial
    • News
        • Anesthesiology
        • Cancer
        • Cardiac Sciences
        • Critical Care
        • Dentistry
        • Dermatology
        • Diabetes and Endo
        • Diagnostics
        • ENT
        • Featured Research
        • Gastroenterology
        • Geriatrics
        • Medicine
        • Nephrology
        • Neurosciences
        • Nursing
        • Obs and Gynae
        • Ophthalmology
        • Orthopaedics
        • Paediatrics
        • Parmedics
        • Pharmacy
        • Psychiatry
        • Pulmonology
        • Radiology
        • Surgery
        • Urology
    • Practice Guidelines
        • Anesthesiology Guidelines
        • Cancer Guidelines
        • Cardiac Sciences Guidelines
        • Critical Care Guidelines
        • Dentistry Guidelines
        • Dermatology Guidelines
        • Diabetes and Endo Guidelines
        • Diagnostics Guidelines
        • ENT Guidelines
        • Featured Practice Guidelines
        • Gastroenterology Guidelines
        • Geriatrics Guidelines
        • Medicine Guidelines
        • Nephrology Guidelines
        • Neurosciences Guidelines
        • Obs and Gynae Guidelines
        • Ophthalmology Guidelines
        • Orthopaedics Guidelines
        • Paediatrics Guidelines
        • Psychiatry Guidelines
        • Pulmonology Guidelines
        • Radiology Guidelines
        • Surgery Guidelines
        • Urology Guidelines
    LoginRegister
    Speciality Medical Dialogues
    LoginRegister
    • Home
    • Editorial
    • News
      • Anesthesiology
      • Cancer
      • Cardiac Sciences
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endo
      • Diagnostics
      • ENT
      • Featured Research
      • Gastroenterology
      • Geriatrics
      • Medicine
      • Nephrology
      • Neurosciences
      • Nursing
      • Obs and Gynae
      • Ophthalmology
      • Orthopaedics
      • Paediatrics
      • Parmedics
      • Pharmacy
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
    • Practice Guidelines
      • Anesthesiology Guidelines
      • Cancer Guidelines
      • Cardiac Sciences Guidelines
      • Critical Care Guidelines
      • Dentistry Guidelines
      • Dermatology Guidelines
      • Diabetes and Endo Guidelines
      • Diagnostics Guidelines
      • ENT Guidelines
      • Featured Practice Guidelines
      • Gastroenterology Guidelines
      • Geriatrics Guidelines
      • Medicine Guidelines
      • Nephrology Guidelines
      • Neurosciences Guidelines
      • Obs and Gynae Guidelines
      • Ophthalmology Guidelines
      • Orthopaedics Guidelines
      • Paediatrics Guidelines
      • Psychiatry Guidelines
      • Pulmonology Guidelines
      • Radiology Guidelines
      • Surgery Guidelines
      • Urology Guidelines
    • Home
    • FDA

    Tag: fda

    You Searched For "FDA"
    Oxbryta- New drug for Sickle cell disease receives FDA approval

    Oxbryta- New drug for Sickle cell disease receives FDA approval

    Hina Zahid26 Nov 2019 7:25 PM IST
    U.S. Food and Drug Administration has granted accelerated approval to Oxbryta (voxelotor) for the treatment of sickle cell disease (SCD) in adults and...
    FDA approves higher-dose insulin glargine for pediatric patients

    FDA approves higher-dose insulin glargine for pediatric patients

    Hina Zahid29 Nov 2019 7:05 PM IST
    The US Food and Drug Administration (FDA) has approved an expanded indication for insulin glargine injection 300 Units/mL (Toujeo) for the management...
    FDA grants Psilocybin breakthrough therapy designation for major depression again

    FDA grants Psilocybin breakthrough therapy designation for major depression again

    Hina Zahid6 Dec 2019 7:05 PM IST
    The U.S. Food and Drug Administration designated psilocybin, a compound found in hallucinogenic mushrooms, as a "breakthrough therapy" for the...
    FDA approves first adjunctive drug to reduce CV risk in patients with elevated triglycerides

    FDA approves first adjunctive drug to reduce CV risk in patients with elevated triglycerides

    Dr. Kamal Kant Kohli Kohli13 Dec 2019 7:15 PM IST
    Food and drugs administration has approved first drug to reduce cardiovascular risk among patients with elevated triglyceride on maximum dose of...
    FDA okays first interoperable, automated insulin pump

    FDA okays first interoperable, automated insulin pump

    Hina Zahid15 Dec 2019 9:00 AM IST
    FDA has cleared first interoperable, automated insulin pump.Tandem Diabetes Care's updated t:slim X2 can pair with a Dexcom G6 glucose monitor to...
    FDA Panel votes in favour of Teprotumumab for Thyroid Eye Disease

    FDA Panel votes in favour of Teprotumumab for Thyroid Eye Disease

    Hina Zahid17 Dec 2019 7:05 PM IST
    A US Food and Drug Administration (FDA) advisory panel has voted in favour of the approval of teprotumumab solution for intravenous use(Horizon...
    FDA approves tazarotene lotion for acne treatment

    FDA approves tazarotene lotion for acne treatment

    Dr. Kamal Kant Kohli Kohli22 Dec 2019 7:28 PM IST
    The U.S. Food and Drug Administration (FDA) has approved the New Drug Application for ARAZLOTM (tazarotene) Lotion, 0.045%, for the topical treatment...
    FDA approves Enhertu for patients with HER2-positive breast cancer

    FDA approves Enhertu for patients with HER2-positive breast cancer

    Hina Zahid22 Dec 2019 9:05 AM IST
    U.S. Food and Drug Administration granted accelerated approval to Enhertu (fam-trastuzumab deruxtecan-nxki) for the treatment of adults with...
    FDA approves ubrogepant for acute migraine in adults

    FDA approves ubrogepant for acute migraine in adults

    Hina Zahid23 Dec 2019 7:15 PM IST
    The US Food and Drug Administration (FDA) has approved ubrogepant (Ubrelvy) for the acute treatment of migraine with or without aura in adults in...
    FDA approves first generics for apixaban

    FDA approves first generics for apixaban

    Hina Zahid24 Dec 2019 7:15 PM IST
    The US Food and Drug Administration (FDA) has announced the approval of 2 applications for the first generics for apixaban (Eliquis) for reducing the...
    FDA clears Medactas MyShoulder placement guides

    FDA clears Medacta's MyShoulder placement guides

    Hina Zahid30 Dec 2019 7:05 PM IST
    Medacta has announced receiving FDA clearance for their MyShoulder Placement Guides for shoulder arthroplasty. These patient-matched, 3D-printed...
    FDA approves Control-IQ artificial pancreas system

    FDA approves Control-IQ artificial pancreas system

    Hina Zahid2 Jan 2020 7:20 PM IST
    The U.S. Food and Drug Administration has approved an artificial pancreas system that automatically monitors and regulates blood sugar levels. The...
    PrevNext

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 12 Oct 2022 7:06 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok